Manulife (Manufacturers Life Insurance)’s Kezar Life Sciences KZR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,770
Closed -$16K 3014
2024
Q1
$16K Sell
1,770
-10
-0.6% -$91 ﹤0.01% 2932
2023
Q4
$16.9K Sell
1,780
-99
-5% -$870 ﹤0.01% 2946
2023
Q3
$22.4K Sell
1,879
-1,377
-42% -$24.4K ﹤0.01% 2958
2023
Q2
$79.8K Buy
3,256
+1,193
+58% +$31.1K ﹤0.01% 2918
2023
Q1
$64.6K Hold
2,063
﹤0.01% 2824
2022
Q4
$145K Buy
2,063
+204
+11% +$15.1K ﹤0.01% 2695
2022
Q3
$160K Sell
1,859
-86
-4% -$8.36K ﹤0.01% 2678
2022
Q2
$161K Buy
1,945
+487
+33% +$43K ﹤0.01% 2755
2022
Q1
$242K Sell
1,458
-248
-15% -$35.6K ﹤0.01% 2643
2021
Q4
$285 Buy
1,706
+270
+19% +$30.5K ﹤0.01% 2638
2021
Q3
$124K Buy
+1,436
New +$95K ﹤0.01% 3089
2021
Q2
Sell
-2,114
Closed -$126K 3255
2021
Q1
$126K Sell
2,114
-222
-10% -$13K ﹤0.01% 3018
2020
Q4
$122K Buy
2,336
+525
+29% +$29.2K ﹤0.01% 2923
2020
Q3
$88K Buy
1,811
+95
+6% +$4.54K ﹤0.01% 2821
2020
Q2
$94K Buy
1,716
+363
+27% +$18.3K ﹤0.01% 2771
2020
Q1
$59K Buy
+1,353
New +$55K ﹤0.01% 2710

Other funds holding KZR

Manulife (Manufacturers Life Insurance)'s KZR Position: Q2 2024 in Review

Manulife (Manufacturers Life Insurance) sold out of Kezar Life Sciences (KZR) in Q2 2024, closing a stake of 1,770 shares — an estimated $16K sold.

Manulife (Manufacturers Life Insurance) first reported a position in KZR in Q1 2020 and held it in 16 quarters. The position peaked at $242K in Q1 2022. 81 funds tracked by Wall St. Rank hold KZR as of Q2 2024.

  • Manulife (Manufacturers Life Insurance) reported no remaining Kezar Life Sciences position as of Q2 2024 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 1,770 Kezar Life Sciences shares in Q2 2024, an estimated $16K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Kezar Life Sciences in Q1 2020 and held it in 16 quarters.
  • Manulife (Manufacturers Life Insurance)'s Kezar Life Sciences position peaked at $242K in Q1 2022.
  • 81 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q2 2024.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2024, filed 14 Aug 2024.